Insider filing · ROIV
Richard Pulik
CFO
profile →
Roivant Sciences Ltd.
ROIV · Healthcare · 74 filings in 24 months
ticker →
Richard Pulik sold $9.1M of Roivant Sciences (ROIV)
Executed Dec 23 2025, disclosed Dec 29 2025, 6 days later, against a two-business-day limit.
Value, as filed
$9.1M
406,731 sh across 2 lots
Executed
Dec 23 2025
the trade date, as filed
Disclosed
Dec 29 2025
6 days after the trade · past the deadline
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
RPRichard Pulik (CFO) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale, 1 filed past the two-business-day deadline), most often in Roivant Sciences Ltd. (ROIV). The largest single filing was $9.1M of ROIV (406,731 sh across 2 lots, as filed), executed Dec 23 2025.
The name
ROIVHealthcare · Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicine…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→